Urispas
Generic name: Flavoxate
Drug class:
Urinary antispasmodics
Usage of Urispas
Urispas reduces muscle spasms of the bladder and urinary tract.
Urispas is used to treat bladder symptoms such as painful urination, frequent or urgent urination, increased night-time urination, bladder pain, and incontinence (urine leakage). These bladder symptoms are often caused by overactive bladder, prostate enlargement, bladder infections, or irritation of the urethra.
Urispas will not treat a bladder infection. Infections must be treated with an antibiotic.
Urispas may also be used for purposes not listed in this medication guide.
Urispas side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Common side effects of Urispas may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Urispas
You should not use Urispas if you are allergic to it, or if you have:
To make sure Urispas is safe for you, tell your doctor if you have:
Urispas is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
It is not known whether Flavoxate passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Urispas is not approved for use by anyone younger than 12 years old.
Relate drugs
- Anturol
- Atropine, hyoscyamine, methenamine, methylene blue, phenyl salicylate, and benzoic acid
- Azuphen MB
- Myrbetriq
- Myrbetriq Granules
- Darifenacin
- Detrol
- Detrol LA
- Ditropan
- Ditropan XL
- Enablex
- Fesoterodine
- Flavoxate
- Gelnique
- Gelnique transdermal
- Gemtesa
- Hyolev MB
- Hyoscyamine, methenamine, methylene blue, and sodium biphosphate
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, and sodium phosphate
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate
- Mirabegron
- Oxybutynin
- Oxybutynin (Oral)
- Oxybutynin transdermal
- Oxytrol
- Phosphasal
- Prosed EC
- Sanctura
- Sanctura XR
- Solifenacin
- Tolterodine
- Toviaz
- Trac Tabs
- Trospium
- UR N-C
- Uramit MB
- Urelle
- Uretron D/S
- Uribel
- Urimar-T
- Urin D/S
- Urised
- Urispas
- Uro-L
- Uro-MP
- Urogesic-Blue
- Ustell
- UTA
- Uticap
- Utira-C
- Utrona-C
- VESIcare
- VESIcare LS
- Vibegron
- Vilamit MB
- Vilevev MB
How to use Urispas
Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.
Your doctor may occasionally change your Urispas dose to make sure you get the best results.
Call your doctor if your symptoms do not improve, or if they get worse.
If your doctor has also prescribed medicine to treat a bladder infection, use that medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics.
Store Urispas at room temperature away from moisture, heat, and light.
Warnings
You should not use Urispas if you have bleeding or a blockage in your digestive tract (stomach or intestines), a bladder obstruction, or if you are unable to urinate.
What other drugs will affect Urispas
Other drugs may interact with flavoxate, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions